Sumitomo Dainippon Chair Sees No Need for Further Consolidation among Japan Drug Makers

Sumitomo Dainippon Chairman Masayo Tada Japanese drug makers no longer need to merge with domestic peers in the pursuit of scale as there is less rationale for such move now that their focus is increasingly shifting to open innovation and...read more